Kitazato Corporation (368A) Balance sheet

Market cap
¥53.4B
P/E ratio
15.3x
Kitasato Corporation develops and manufactures medical devices and reagents for reproductive medicine including IVF and egg freezing, serving hospitals and clinics in over 110 countries worldwide.
2022/032023/032024/032025/03
Cash and cash equivalents -8,09910,50411,460
Total cash & short-term investments-8,09910,50411,460
Inventories-321342388
Total current assets-11,36313,71114,835
Property, plant and equipment, net-3,7713,7644,552
Total non-current assets-4,1384,1454,913
Total assets -15,50117,85719,748
Total current liabilities-1,3131,6751,419
Total non-current liabilities-10112179
Total liabilities -1,4141,7961,499
Retained earnings-14,07716,05018,239
Stockholders' equity11,91614,08716,06018,249
AI Chat